期刊文献+

Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation 被引量:14

Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation
下载PDF
导出
摘要 AIM: To investigate the relationship between contrastenhanced ultrasound(CEUS),basic fibroblast growth factor(b FGF),endothelin-1(ET-1),and hepatocellular carcinoma(HCC) recurrence after ablation. METHODS: A total of 51 HCC patients(38 males and 13 females) who received radiofrequency ablation in our hospital from June 2012 to July 2014 were enrolled in this study. The patients were divided into two groups: recurrence group and non-recurrence group. Routine abdominal examination was first performed in the horizontal position. Then the patients underwent CEUS and immunohistochemical staining before receiving radiofrequency ablation. All patients were followed-up every three months for one year.The results of CEUS and serum tumor marker levels were evaluated and combined together to estimate HCC recurrence and metastasis. Patients were divided into two groups: recurrence group and non-recurrence group. Quantitative parameters of CEUS and tumor expression levels of b FGF and ET-1 were compared between the two groups,respectively. Binary logistic regression analysis was used to analyze the relationship between CEUS quantitative parameters,expression levels of ET-1 and b FGF,and HCC recurrence after ablation. RESULTS: Based on the quantitative parameters of CEUS before patients received radiofrequency ablation,the levels of tumor rise time(t RT),tumor time to peak(t TTP),tumor peak intensity(t PI) and tumorparenchymal peak intensity(t-p PI) in the recurrence group were significantly lower than those in the nonrecurrence group(16.6 ± 6.1 vs 23.2 ± 7.0,P = 0.000; 41.2 ± 10.2 vs 59.6 ± 14.2,P = 0.000; 23.8 ± 6.7 vs 31.4 ± 6.4,P = 0.000; 7.1 ± 3.4 vs 14.6 ± 7.4,P = 0.000; respectively). The expression levels of b FGF in the recurrence group were significantly higher than those in the non-recurrence group(P < 0.05). Levels of t TTP showed a significant inverse correlation with the level of b FGF in tumors(r =-0.312,P = 0.037). The Binary logistic regression analysis results revealed that the levels of t RT,t TTP,t PI and the level of b FGF were associated with HCC recurrence after radiofrequency ablation(P < 0.05). CONCLUSION: CEUS is a noninvasive and effective method for evaluating the angiogenesis of HCC,and predicting its recurrence and prognosis. AIM: To investigate the relationship between contrastenhanced ultrasound(CEUS),basic fibroblast growth factor(b FGF),endothelin-1(ET-1),and hepatocellular carcinoma(HCC) recurrence after ablation. METHODS: A total of 51 HCC patients(38 males and 13 females) who received radiofrequency ablation in our hospital from June 2012 to July 2014 were enrolled in this study. The patients were divided into two groups: recurrence group and non-recurrence group. Routine abdominal examination was first performed in the horizontal position. Then the patients underwent CEUS and immunohistochemical staining before receiving radiofrequency ablation. All patients were followed-up every three months for one year.The results of CEUS and serum tumor marker levels were evaluated and combined together to estimate HCC recurrence and metastasis. Patients were divided into two groups: recurrence group and non-recurrence group. Quantitative parameters of CEUS and tumor expression levels of b FGF and ET-1 were compared between the two groups,respectively. Binary logistic regression analysis was used to analyze the relationship between CEUS quantitative parameters,expression levels of ET-1 and b FGF,and HCC recurrence after ablation. RESULTS: Based on the quantitative parameters of CEUS before patients received radiofrequency ablation,the levels of tumor rise time(t RT),tumor time to peak(t TTP),tumor peak intensity(t PI) and tumorparenchymal peak intensity(t-p PI) in the recurrence group were significantly lower than those in the nonrecurrence group(16.6 ± 6.1 vs 23.2 ± 7.0,P = 0.000; 41.2 ± 10.2 vs 59.6 ± 14.2,P = 0.000; 23.8 ± 6.7 vs 31.4 ± 6.4,P = 0.000; 7.1 ± 3.4 vs 14.6 ± 7.4,P = 0.000; respectively). The expression levels of b FGF in the recurrence group were significantly higher than those in the non-recurrence group(P < 0.05). Levels of t TTP showed a significant inverse correlation with the level of b FGF in tumors(r =-0.312,P = 0.037). The Binary logistic regression analysis results revealed that the levels of t RT,t TTP,t PI and the level of b FGF were associated with HCC recurrence after radiofrequency ablation(P < 0.05). CONCLUSION: CEUS is a noninvasive and effective method for evaluating the angiogenesis of HCC,and predicting its recurrence and prognosis.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第36期10418-10426,共9页 世界胃肠病学杂志(英文版)
关键词 CONTRAST-ENHANCED ULTRASONOGRAPHY HEPATOCELLULAR c Contrast-enhanced ultrasonography Hepatocellular c
  • 相关文献

参考文献13

  • 1Ming‐Lun Han,Chieh‐Chang Chen,Shih‐Hao Kuo,Wen‐Feng Hsu,Jyh‐Ming Liou,Ming‐Shiang Wu,Hsiu‐Po Wang.Predictors of in‐hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis[J]. J Gastroenterol Hepatol . 2014 (2)
  • 2D. Strobel,T. Bernatik,W. Blank,A. Schuler,C. Greis,C. Dietrich,K. Seitz.Diagnostische Treffsicherheit des kontrastmittelverst?rkten Ultraschalls in der Differentialdiagnose kleiner (≤ 20 mm) und kleinster (≤ 10 mm) solider Leberraumforderungen im Vergleich zur Histologie[J]. Ultraschall in Med . 2011 (06)
  • 3IreneFloriani,ValterTorri,ElianaRulli,DanielaGaravaglia,AnnaCompagnoni,LucaSalvolini,AndreaGiovagnoni.Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: A systematic review and meta‐analysis[J]. J. Magn. Reson. Imaging . 2009 (1)
  • 4Keiichiro Sakuma,Masahiro Aoki,Reiji Kannagi.Transcription factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced epithelial-mesenchymal transition. Proceedings of the National Academy of Sciences of the United States of America . 2012
  • 5Welzel TM,Graubard BI,Zeuzem S,El-Serag HB,Davila JA,McGlynn KA.Metabolic syndrome increases the risk of primary liver cancer in the United States:a study in the SEER-Medicare database. Hepatology . 2011
  • 6JH Zhou,LH Cao,JB Liu,W Zheng,M Liu,RZ Luo,F Han,AH Li.Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US. Radiology . 2011
  • 7Chen LD,Xu HX,Xie XY,et al.Intrahepatic cholangiocarcinoma and hepatocellular carcinoma;differential diagnosis with contrast-enhanced ultrasound. European Radiology . 2010
  • 8Feng YX,Wang T,Deng YZ,Yang P,Li JJ,Guan DX,Yao F,Zhu YQ,Qin Y,Wang H,Li N,Wu MC,Wang HY,Wang XF,Cheng SQ,Xie D.Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model. Hepatology . 2011
  • 9Xi Jiafei,Wang Yunfang,Zhang Peng,He Lijuan,Nan Xue,Yue Wen,Pei Xuetao.Human fetal liver stromal cells that overexpress bFGF support growth and maintenance of human embryonic stem cells. PloS one . 2011
  • 10Cao XL,Bao W,Zhu SG,et al.Contrast-enhanced ultrasound characteristics of breast cancer:correlation with prognostic factors. Ultrasound in Medicine and Biology . 2014

共引文献5

同被引文献119

引证文献14

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部